Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Medullary × ponatinib × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Neoplasms 6 Leukemia 5 Neoplasms by Histologic Type 4 Myeloproliferative Disorders 4 Leukemia, Myeloid 4 Hematologic Diseases 4 Bone Marrow Diseases 4 Carcinoma, Non-Small-Cell Lung 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoproliferative Disorders 2 Lymphatic Diseases 2 Leukemia, Myeloid, Chronic-Phase 2 Immunoproliferative Disorders 2 Immune System Diseases 2 Thyroid Neoplasms 1 Small Cell Lung Carcinoma 1 Piebaldism 1 Malignant Hepatobiliary Neoplasm 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Head and Neck Neoplasms 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Gastrointestinal Neoplasms 1 Carcinoma, Squamous Cell 1 Blast Crisis 1 Adenocarcinoma of Lung 1

Interventions

vandetanib 9 cabozantinib 4 selpercatinib 3 Sunitinib 2 Sorafenib 2 yeast-CEA vaccine 1 tanespimycin 1 pralsetinib 1 pembrolizumab 1 pazopanib 1 lenvatinib 1 Vorinostat 1 Temozolomide 1 Pharmacogenomic Testing 1 Magnetic Resonance Spectroscopy 1 Lithium Carbonate 1 Irinotecan 1 Gefitinib 1 Ferrosoferric Oxide 1 Capecitabine 1 Bortezomib 1 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡